BlogHeader.png

Jonathan Granger

Recent Posts by Jonathan Granger:

Alcami Pays Tribute to Fallen Patriots this Memorial Day

Alcami joined the nation in remembering and honoring fallen members of the U.S. Armed Forces this Memorial Day with a donation to the Purple Heart Foundation and a strong public showing of support for longtime Alcami employee and Vietnam veteran, Herman Anthony.

In a special tribute to the brave men and women who sacrificed their lives in service to our country, Anthony was invited by the Milwaukee Brewers to participate in a May 26 ceremony on the Miller Park playing field during the national anthem.

Topics: Company News Alcami in Action

Alcami Supports Homestead High School’s Varsity Robotics Club

Alcami continues to make science, technology, engineering, and mathematics (STEM) education and training initiatives a priority in 2019, this time partnering with Homestead High School in Mequon, Wisconsin, to support the school’s growing robotics club. The company has agreed to sponsor Homestead’s 2019 competitions and demonstrations, which will help its club purchase new computers and 3D printers. On average, teams invest approximately $4,000 to build a robot from the ground up and participate in competitions.

Topics: Company News Alcami in Action

Alcami and Students 2 Science Inspire Future Scientists

Students 2 Science (S2S) is a New Jersey-based nonprofit committed to inspiring and educating elementary, middle, and high school students to pursue careers in science, technology, engineering, and mathematics (STEM). Through strategic partnerships between businesses, institutions of higher education, district leadership, and workforce-readiness agencies, S2S provides students with real life laboratory problem-solving experiences led by scientific professionals using modern technology and instrumentation. S2S’s V-Laboratory educational program enlists corporate partners such as Alcami to serve as in-class mentors and help introduce students to the broad spectrum of STEM careers available to them.

Topics: Company News Alcami in Action

Alcami St. Louis Facility Issued European Medicines Agency Certification

Alcami’s St. Louis, Missouri Center of Excellence for advanced analytical testing was issued a Certificate of Compliance by the European Medicines Agency (EMA) Tuesday, April 23, 2019, following the facility’s recent successful Good Manufacturing Practice (GMP) inspection. Certification confirms the site is compliant with GMP laboratory storage and testing practices, and enables the laboratory to process more commercial products for the European Union (EU). The outcome reflects the company’s unwavering commitments to quality, reliability, responsible operations, and strict adherence to regulatory compliance.

Topics: Company News Regulatory Compliance Analytical Testing Analytical Development

Alcami Celebrates Earth Day with Community Cleanups

Alcami employees, their families, and friends celebrated Earth Day 2019 by cleaning up green spaces, beaches, waterways, sidewalks, and streets in the company’s local communities. More than 30 volunteers participated in this year’s preservation efforts, including cleanups at Wrightsville Beach, Carolina Beach, and Isle of Palms Beach, near Wilmington, North Carolina and Charleston, South Carolina; business park and nature trail litter removal in Germantown, Wisconsin; and growing new plant life in Durham, North Carolina. Combined, these efforts will protect native wildlife and enhance public gathering places for all to enjoy.

Topics: Company News Alcami in Action

Alcami Kickstarts Biologics Enterprise to Advance Treatments for Complex Medical Conditions

Durham, NC (USA) – March 19, 2019 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today launched Alcami Biologics, the organization’s new biopharmaceutical development, analytical testing, manufacturing, and packaging enterprise. Alcami Biologics will advance the commercialization of a wide range of biological products to treat complex medical conditions with unmet needs. This comes in response to increased market demand for outsourced biological drug development services.

Topics: Company News Biologics Manufacturing Analytical Testing Development Analytical Development Packaging Drug Product Parenteral Manufacturing

Alcami STEAM Outreach Efforts Aim to Inspire Students, Advance Workforce

Alcami expanded its Science, Technology, Engineering, Arts, and Math (STEAM) education initiatives this fall with three specialized outreach events designed to encourage high school and college students to pursue careers in chemistry, engineering, and other STEAM fields. 

On October 30, 2018, Divine Savior Holy Angels High School (DSHA) students got a behind-the-scenes look at Alcami’s Germantown, Wisconsin active pharmaceutical ingredient (API) Center of Excellence, as part of the company’s ongoing efforts to promote women in STEAM careers. The all-girls engineering class toured the campus, met with key female company leaders, and learned about potential career paths through interactive presentations.

Topics: Company News Alcami in Action

Alcami Employee Recognized with Honor Flight

The nonprofit Honor Flight Network honors America’s military veterans for their sacrifices by transporting as many of them as possible to see the Washington, D.C. memorials of the wars they fought in, at no cost to them. Alcami employee and Vietnam veteran, Herman Anthony, was recently selected for an Honor Flight, and was accompanied by Milwaukee Brewers all-star relief pitcher, Corey Knebel. Herman received a hero’s welcome at the Milwaukee airport from Alcami colleagues, friends, family, and the general public. He recently spoke with Alcami's Marketing & Corporate Communications team to discuss his experience.

Topics: Company News Alcami in Action

Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

Durham, NC (USA) – October 25, 2018 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, announced today its collaboration with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company dedicated to the development of affordable medicines and vaccines for neglected diseases prevalent in low and middle-income countries. MDGH recently received U.S. Food and Drug Administration (FDA) approval of moxidectin, a novel new drug for the treatment of river blindness (onchocerciasis). MDGH utilized Alcami’s advanced analytical testing services and industry-leading accelerated turnaround time offering to meet critical approval deadlines.

Topics: Company News Analytical Testing Development Analytical Development Drug Product

Alcami and UNCW Awarded Biomanufacturing Workforce Development Grant

Project Call 1.0 Proposal Selected by NIIMBL Governing Committee

Durham, NC (USA) – August 30, 2018 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, and the University of North Carolina Wilmington (UNCW), North Carolina’s globally-minded research and development university, today announce they have been awarded an educational grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), an organization comprised of companies, educational institutions, nonprofits, and state governments dedicated to accelerating biopharmaceutical manufacturing innovation, developing industry standards, and educating and training a pipeline of skilled workers for the field’s abundant well-paying jobs. The grant will fund the UNCW program “Partnership for Workforce Development in the Biopharmaceutical Industry,” which will be co-developed and taught by Alcami subject matter experts.

Topics: Company News Alcami in Action